PAPER McLennon SM, Habermann B, Davis LL
SEARCH RESULTS
331254 RESULTS
PAPER Gustavsson A, Jonsson L, Fillit H, Johansson G, Wimo A, Winblad B
IPECAD5--Fifth International Pharmaco-Economic Conference on Alzheimer's Disease.
J Nutr Health Aging. 2010 May;14(5):358-60. PubMed: 20424802PAPER Kekovic G, Culic M, Martac L, Stojadinovic G, Capo I, Lalosevic D, Sekulic S
Fractal dimension values of cerebral and cerebellar activity in rats loaded with aluminium.
Med Biol Eng Comput. 2010 Jul;48(7):671-9. PubMed: 20424923PAPER van Rooijen BD, Claessens MM, Subramaniam V
Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.
Curr Protein Pept Sci. 2010 Aug;11(5):334-42. PubMed: 20423294PAPER Stefani M
Structural polymorphism of amyloid oligomers and fibrils underlies different fibrillization pathways: immunogenicity and cytotoxicity.
Curr Protein Pept Sci. 2010 Aug;11(5):343-54. PubMed: 20423295PAPER Buratti E, De Conti L, Stuani C, Romano M, Baralle M, Baralle F
Nuclear factor TDP-43 can affect selected microRNA levels.
FEBS J. 2010 May;277(10):2268-81. PubMed: 20423455PAPER Smith AM, Gibbons HM, Dragunow M
Valproic acid enhances microglial phagocytosis of amyloid-beta(1-42).
Neuroscience. 2010 Aug 11;169(1):505-15. PubMed: 20423723PAPER Sun G, Alzayady K, Stewart R, Ye P, Yang S, Li W, Shi Y
Histone demethylase LSD1 regulates neural stem cell proliferation.
Mol Cell Biol. 2010 Apr;30(8):1997-2005. PubMed: 20123967PAPER Kronenberg G, Endres M
Neuronal injury: folate to the rescue?
J Clin Invest. 2010 May 3;120(5):1383-6. PubMed: 20424316Ruth Itzhaki on Toronto: In Small Trial, IVIg Slows Brain Shrinkage
COMMENT The trial of IVIg (Gammagard) for treating AD patients was done with the aim of augmenting their relatively low level of anti-Aβ antibodies, thereby enhancing the clearance of Aβ. We wonder if, instead, the beneficial effect of IVIg might have been throug
PAPER Masci S, De Simone C, Famularo G, Gravante M, Ciancarelli M, Andreassi M, Amerio P, Santini G
Intravenous immunoglobulins suppress the recurrences of genital herpes simplex virus: a clinical and immunological study.
Immunopharmacol Immunotoxicol. 1995 Feb;17(1):33-47. PubMed: 7759773PAPER Erlich KS, Mills J
Passive immunotherapy for encephalitis caused by herpes simplex virus.
Rev Infect Dis. 1986 Jul-Aug;8 Suppl 4:S439-45. PubMed: 3018895PAPER Kohl S, Loo LS
In vitro and in vivo antibody-dependent cellular cytotoxicity of intravenous immunoglobulin G preparations against herpes simplex virus.
Rev Infect Dis. 1986 Jul-Aug;8 Suppl 4:S446-8. PubMed: 3018896Steve Barger on Another Screen, Another Gene: ALS and the Right-handed Serine
COMMENT Regarding the statement in this news story "De Belleroche also pointed out that a DAO mutant mouse might be a useful model for ALS research, which sorely needs new models," I'd like to note that it is unlikely that loss of DAO alone will be
PAPER Konno R, Yasumura Y
Mouse mutant deficient in D-amino acid oxidase activity.
Genetics. 1983 Feb;103(2):277-85. PubMed: 6131852Current Filters
No filters selected